Why is Arm stock sliding today?

Arm Holdings stock is sliding 3.4% in pre-open trading today after the British chip designer’s fiscal second-quarter earnings report, released after Wednesday’s close, delivered solid but insufficiently impressive results to satisfy a market that had priced in exceptional forward momentum.

While revenue of $1.44 billion and adjusted earnings per share of $0.52 both cleared Wall Street’s consensus forecasts, third-quarter revenue guidance of approximately $1.54 billion only barely edged past analyst expectations of $1.53 billion — a margin too slim to justify the stock’s lofty valuation.

A key source of investor disappointment was the royalty revenue segment, which grew just 8% year-over-year to $670 million. Royalties are closely watched because they reflect actual chip shipments by Arm’s licensees, and the relatively modest growth rate stood in sharp contrast to the 50% surge in licensing revenue.

Several major banks moved swiftly to revise their outlooks: Goldman Sachs reiterated a Sell rating with a $160 price target, arguing the stock would remain range-bound; HSBC trimmed its target to $215 from $230 while holding a neutral stance; and Barclays cut its target to $325 from $360, citing margin pressure from the AGI CPU hardware business and rising operating expenses. An ongoing licensing dispute with Qualcomm also continued to weigh on sentiment.

The broader market backdrop offered little relief for chip stocks. The Nasdaq Composite was down 0.5%, underperforming the S&P 500’s near-flat session, as semiconductor names bore the brunt of post-earnings selling.

Qualcomm, one of Arm’s most significant licensees and a key competitor in the chip design space, also reported disappointing handset chip revenue the same evening, amplifying concerns across the sector. Asian chipmakers fell in sympathy overnight, reinforcing the negative tone heading into the U.S. pre-market session.

Together, these forces — underwhelming forward guidance, soft royalty growth, a chorus of analyst price target reductions, and weak sector-wide sentiment — combined to push Arm’s shares lower despite the company’s continued double-digit revenue expansion and its ambitious $2 billion AGI CPU revenue target for fiscal years 2027 and 2028.